Download Sobel’s free e-book and understand what changes in the biological evaluation of medical devices — and how to align your processes with the new international requirements.

The new ISO 10993-1:2025 edition marks a major shift in biological safety and risk management for medical devices.
It introduces significant updates — from integration with ISO 14971, to a redesigned contact categorization, increased emphasis on bioaccumulation, and a strong push for animal testing alternatives using 3Rs and NAMs (New Approach Methodologies).
With so many changes, understanding every requirement can take time. That’s why Sobel developed a practical and objective guide to help you quickly understand what truly matters — and how to prepare.
This material is essential for professionals and organizations working with:
Medical devices, in vitro diagnostics (IVDs), dental devices, and related technologies
R&D, Quality, and Regulatory Affairs teams
Manufacturers exporting to highly regulated markets
Health-tech and med-tech startups
This guide was developed by Sobel’s Human Safety specialists — experts who work daily with the practical application of ISO 10993-1 in real product development.
With the same technical expertise, our team supports companies in achieving full compliance with customized, end-to-end solutions:


Our specialists bring more than 20 years of experience in regulatory affairs, biological safety, and biocompatibility. We are a trusted partner for medical device manufacturers seeking compliance with international standards such as ISO 10993-1 and ISO 14971.
Our mission is to combine science, strategy, and compliance to help companies ensure safety and accelerate global market access.
Compliance with ISO 10993-1:2025 is essential for marketing medical devices in major global markets.
Make sure your product remains compliant by staying informed. Download the free e-book and understand exactly what changes in the new biocompatibility edition of ISO 10993-1:2025!